Get started

89bio, Inc.

No trades
See on Supercharts
Overview
News Ideas Financials Technicals Forecast

ETNB chart

Key stats

Market capitalization
593.006MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.00USD
Net income
−102.026MUSD
Revenue
—
Shares float
73.557M
Beta
1.12

About 89bio, Inc.

Sector
Health Technology
CEO
Rohan Palekar
Headquarters
San Francisco
Website
89bio.com
Employees (FY)
45
Founded
2018
ISIN
US2825591033
89bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Its product pipeline includes pegozafermin, FGF21, NASH, and SHTG. The company was founded on January 18, 2018 and is headquartered in San Francisco, CA.

Ideas

ETNB BullishPrice recently filled the gap at $5 and has since closed higher for 3 consecutive days creating a "3 white soldier" pattern. In addition the ADX displays a strong trend with a value of 39 with the D+ indicator rising. Targets: $6.46, $7.81
Long
by Master_of_Fine_Charts
2
ETNB long (longer-term play)ETNB long, longer-term play 89bio, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases. The company was founded on January 01, 2018 and
Long
by freddiegbruh
ETNB large insider trading orders info from secform4.com july8th 275,000 shares bought at $27.5 $7,562,500 dollars worth 10% owner september 21rst 1,300,000 shares bought at $28 $36,400,000 dollars worth director 10% owner a few days after had bank of america upgrade from 37 to 43 dollars target posted on fi
Long
by evnrandy

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Financials

Performance
Revenue to profit conversion
Earnings
‪0‬

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.4Very Good
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.4Very Good
Learn more

See all brokers